Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-1241PMID 16267036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classification of BRCA1 missense variants of unknown clinical significance

  2005cited by this paper
• Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1.

  2005cited by this paper
• Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation

  2004influential reference
• Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.

  2004cited by this paper
• BRCA1 and BRCA2: 1994 and beyond

  2004cited by this paper
• Haplotype analysis of BRCA1 gene reveals a new gene rearrangement: characterization of a 19.9 KBP deletion

  2004cited by this paper
• Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations

  2003cited by this paper
• Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia.

  2003cited by this paper
• A full-likelihood method for the evaluation of causality of sequence variants from family data.

  2003cited by this paper
• Application of haplotype pair analysis for the identification of hemizygous loci

  2003cited by this paper
• The Structure of Haplotype Blocks in the Human Genome

  2002cited by this paper
• Biallelic Inactivation of BRCA2 in Fanconi Anemia

  2002influential reference
• Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations inBRCA1

  2001cited by this paper
• Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: Implications for genetic testing

  2001cited by this paper
• Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

  2001cited by this paper
• Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

  2000cited by this paper
• Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

  1999cited by this paper
• BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives.

  1999cited by this paper
• Yeast-based Assays for Detection and Characterization of Mutations in BRCA1

  1998cited by this paper
• Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

  1998cited by this paper
• The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.

  1998cited by this paper
• Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.

  1998cited by this paper
• Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutation

  1997cited by this paper
• Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC

  1997cited by this paper
• BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

  1997cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996influential reference
• The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

  1996influential reference
• The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• A human BRCA1 gene knockout

  1995cited by this paper
• High frequency mutagenesis by a DNA methyltransferase.

  1992cited by this paper

• Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients

  2025cites this paper
• The Molecular Detection of Germline Mutations in the BRCA1 and BRCA2 Genes Associated with Breast and Ovarian Cancer in a Romanian Cohort of 616 Patients

  2024cites this paper
• The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations

  2023cites this paper
• BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: looking for the hidden meaning.

  2022cites this paper
• MagicalRsq: Machine-learning-based genotype imputation quality calibration

  2022influential citation
• Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12

  2022cites this paper
• Mouse Models for Deciphering the Impact of Homologous Recombination on Tumorigenesis

  2021cites this paper
• Incorporation of semi‐quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes

  2019cites this paper
• Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.

  2019cites this paper
• Human Mutation

  2019cites this paper
• Functional investigation of the BRCA1 Val1714Gly and Asp1733Gly variants by computational tools and yeast transcription activation assay

  2019cites this paper
• Mutation analysis of BRCA 1 / 2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients

  2018cites this paper
• Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients

  2018cites this paper
• Hereditary breast and ovarian cancer in Andalusian families: a genetic population study

  2018cites this paper
• Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India

  2018cites this paper
• BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype

  2017cites this paper
• University of Groningen A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history Garcia,

  2015cites this paper
• BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review

  2015cites this paper
• BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

  2015cites this paper
• Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

  2014cites this paper
• BRCA 1 and BRCA 2 unclassi fi ed variants and missense polymorphisms in Algerian breast / ovarian cancer families

  2014cites this paper
• Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation.

  2014cites this paper
• Analysis of BRCA1 Variants in Double‐Strand Break Repair by Homologous Recombination and Single‐Strand Annealing

  2013cites this paper
• BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.

  2013cites this paper
• Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

  2013cites this paper
• BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients.

  2013cites this paper
• BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families

  2012cites this paper
• Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia.

  2012cites this paper
• The BRCT Signaling 'Landscape': Emerging Concepts and Implications in Tumorigenesis and Cancer Diagnostics

  2012cites this paper
• Improving the risk assessment of inherited breast and ovarian cancer : clinical significance of BRCA1/2 variants and risk modifiers

  2012cites this paper
• Classification of missense substitutions in the BRCA genes: A database dedicated to Ex‐UVs

  2012cites this paper
• BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity

  2012influential citation
• BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin

  2012cites this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

  2011cites this paper
• The Role of BRCA1 Domains and Motifs in Tumor Suppression

  2011cites this paper
• In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein

  2011cites this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA 1 / BRCA 2 databases

  2011cites this paper
• Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.

  2010cites this paper
• Alternative splicing and molecular characterization of splice site variants: BRCA1 c.591C>T as a case study.

  2010cites this paper
• Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair

  2010cites this paper
• A recombination-based method to characterize human BRCA1 missense variants

  2010cites this paper
• Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study

  2010cites this paper
• Unclassified sequence variants (UVS) and genetic predisposition to cancer

  2010cites this paper
• BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer

  2009cites this paper
• Human MutationMETHODS A Yeast Recombination Assay to Characterize Human BRCA 1 Missense Variants of Unknown Pathological Significance

  2009influential citation
• A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance

  2009cites this paper
• Efficiency of BRCAPRO and Myriad II mutation probability thresholds versus cancer history criteria alone for BRCA1/2 mutation detection

  2009cites this paper
• Characterisation of gene expression profiles of yeast cells expressing BRCA1 missense variants.

  2009cites this paper
• Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1.

  2009cites this paper
• A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history

  2009cites this paper
• UvA-DARE ( Digital Academic Repository ) A method to assess the clinical significance of unclassified variants in the BRCA 1 and BRCA 2 genes based on cancer family history

  2009cites this paper
• Analysis of BRCA1/BRCA2 genes’ contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women

  2008cites this paper
• Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer

  2008influential citation
• In silico analysis of missense substitutions using sequence‐alignment based methods

  2008cites this paper
• G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history

  2008cites this paper
• Genetic evidence and integration of various data sources for classifying uncertain variants into a single model

  2008cites this paper
• Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators.

  2008cites this paper
• BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy.

  2008cites this paper
• Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.

  2008cites this paper
• New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia

  2008cites this paper
• Functional assays for classification of BRCA2 variants of uncertain significance.

  2008influential citation
• Deciphering the Clinical Significance of BRCA Variants

  2008cites this paper
• Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients

  2008cites this paper
• Automated Processing of Forensic Casework Samples Using Robotic Workstations Equipped with Nondisposable Tips: Contamination Prevention

  2008cites this paper
• BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases

  2008cites this paper
• A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.

  2007cites this paper
• Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.

  2007cites this paper
• Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information

  2007cites this paper
• Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

  2006cites this paper
• Functional implications of BRCA1 for early detection, prevention, and treatment of breast cancer.

  2006cites this paper
• BRCA 1 / 2 SequenceVariantsofUncertainSignificance : APrimer for Providers toAssist inDiscussionsand inMedicalManagement

  year unknowncites this paper